FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and deals with composition for application in treatment of ear diseases by intra-tympanum introduction into membrane of cochlea window or near membrane of cochlea window, which contains, acceptable for ear treatment thermoreversible water gel, which contains polymer of polyoxypropylene and polyoxyethylene and anti-apoptosis agent, slowed release of anti-apoptosis agent into cochlea taking place for, at least, 4 days.
EFFECT: invention ensures constant, slowed, prolonged release of active agent.
10 cl, 26 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR THE TREATMENT OF COCHLEAR SYNAPTOPATHY | 2017 |
|
RU2757276C2 |
| CORTICOSTEROID-BASED COMPOSITION WITH CONTROLLED RELEASE FOR TREATMENT OF EAR DISEASES | 2009 |
|
RU2469726C2 |
| DIBENZO-AZEPINE COMPOUNDS AND USE THEREOF FOR TREATING EAR DISEASES AND DISORDERS | 2016 |
|
RU2707284C1 |
| THERAPY OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY | 2005 |
|
RU2380094C2 |
| METHODS AND COMPOSITIONS FOR APPLYING MOXIFLOXACIN TO EAR | 2011 |
|
RU2576029C2 |
| COMPOSITIONS AND METHODS FOR TREATING CUTANEOUS T-CELL LYMPHOMA | 2014 |
|
RU2669941C2 |
| THERAPEUTIC USE OF THE TLR AGONIST AND COMBINED THERAPY | 2011 |
|
RU2603467C2 |
| BIVALENT INHIBITORS OF IAP PROTEINS AND THERAPEUTIC METHODS OF IMPLEMENTATION | 2013 |
|
RU2649975C2 |
| METHOD FOR TREATMENT OF PATIENTS WITH LARGE INTESTINE CANCER OR LUNG CANCER | 2014 |
|
RU2713555C2 |
| MODULATION OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR ACTIVITY FOR TYMPANIC MEMBRANE HEALING | 2014 |
|
RU2676483C2 |
